Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

CUSIP: 690469101

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
146,457,154
Total 13F shares
42,343,665
Share change
+1,442,023
Total reported value
$162,598,117
Price per share
$3.84
Number of holders
64
Value change
+$5,682,119
Number of buys
23
Number of sells
28

Security key

690469101

Report period

Q3 2023

Institutions

64

Top holders

10

Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BVF INC/IL
13F
Company
4.7%
6,851,051
$22,471,447 30 Jun 2023
13F
EcoR1 Capital, LLC
13F
Company
4.2%
6,117,400
$20,065,072 30 Jun 2023
13F
Rubric Capital Management LP
13F
Company
3.7%
5,445,910
$17,862,585 30 Jun 2023
13F
BlackRock Finance, Inc.
13F
Company
2.3%
3,408,207
$11,178,920 30 Jun 2023
13F
Madison Avenue Partners, LP
13F
Company
2.3%
3,307,605
$10,848,943 30 Jun 2023
13F
VANGUARD GROUP INC
13F
Company
2%
2,899,228
$9,509,468 30 Jun 2023
13F
Artal Group S.A.
13F
Company
1.7%
2,500,000
$8,200,000 30 Jun 2023
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
1.2%
1,780,730
$5,839,000 30 Jun 2023
13F
TLS Advisors LLC
13F
Company
0.9%
1,319,679
$4,329,000 30 Jun 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.83%
1,213,085
$3,978,918 30 Jun 2023
13F
STATE STREET CORP
13F
Company
0.7%
1,026,631
$3,367,350 30 Jun 2023
13F
CHI Advisors LLC
13F
Company
0.59%
864,822
$2,836,616 30 Jun 2023
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.55%
801,152
$2,627,779 30 Jun 2023
13F
NORTHERN TRUST CORP
13F
Company
0.33%
480,803
$1,577,034 30 Jun 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.31%
450,967
$1,479,172 30 Jun 2023
13F
Bank of New York Mellon Corp
13F
Company
0.17%
249,638
$818,812 30 Jun 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.11%
162,647
$533,482 30 Jun 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.1%
142,838
$468,509 30 Jun 2023
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
0.09%
130,000
$426,400 30 Jun 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.08%
114,700
$376,000 30 Jun 2023
13F
Nuveen Asset Management, LLC
13F
Company
0.08%
114,085
$374,199 30 Jun 2023
13F
Tejara Capital Ltd
13F
Company
0.08%
112,591
$369,298 30 Jun 2023
13F
D. E. Shaw & Co., Inc.
13F
Company
0.07%
107,282
$351,885 30 Jun 2023
13F
EA Series Trust
13F
Company
0.07%
98,952
$324,563 30 Jun 2023
13F
Empowered Funds, LLC
13F
Company
0.07%
98,952
$324,563 30 Jun 2023
13F
FMR LLC
13F
Company
0.06%
91,525
$300,202 30 Jun 2023
13F
RHUMBLINE ADVISERS
13F
Company
0.05%
78,768
$258,359 30 Jun 2023
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.05%
69,247
$227,130 30 Jun 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.05%
66,122
$216,880 30 Jun 2023
13F
DCF Advisers, LLC
13F
Company
0.04%
64,764
$212,426 30 Jun 2023
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.04%
62,341
$204,478 30 Jun 2023
13F
MORGAN STANLEY
13F
Company
0.04%
53,644
$175,952 30 Jun 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.04%
52,411
$171,908 30 Jun 2023
13F
UBS Group AG
13F
Company
0.03%
49,626
$162,773 30 Jun 2023
13F
JPMORGAN CHASE & CO
13F
Company
0.03%
47,647
$156,282 30 Jun 2023
13F
BANK OF NOVA SCOTIA
13F
Company
0.03%
44,019
$144,382 30 Jun 2023
13F
Mirae Asset Global Investments Co., Ltd.
13F
Company
0.02%
32,231
$105,718 30 Jun 2023
13F
MetLife Investment Management, LLC
13F
Company
0.02%
31,717
$104,032 30 Jun 2023
13F
CITADEL ADVISORS LLC
13F
Company
0.02%
30,812
$101,063 30 Jun 2023
13F
MARSHALL WACE, LLP
13F
Company
0.02%
30,017
$98,456 30 Jun 2023
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.02%
28,701
$94,139 30 Jun 2023
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
26,800
$87,904 30 Jun 2023
13F
FIRST MANHATTAN CO. LLC.
13F
Company
0.02%
26,000
$85,280 30 Jun 2023
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.02%
25,825
$84,706 30 Jun 2023
13F
OCCUDO QUANTITATIVE STRATEGIES LP
13F
Company
0.02%
25,590
$83,935 30 Jun 2023
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.02%
25,000
$82,000 30 Jun 2023
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.02%
24,850
$81,508 30 Jun 2023
13F
BLAIR WILLIAM & CO/IL
13F
Company
0.02%
23,327
$76,513 30 Jun 2023
13F
Invesco Ltd.
13F
Company
0.02%
22,987
$75,398 30 Jun 2023
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.01%
19,835
$65,059 30 Jun 2023
13F

Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q3 2023

As of 30 Sep 2023, Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,343,665 shares. The largest 10 holders included BVF INC/IL, EcoR1 Capital, LLC, Rubric Capital Management LP, Madison Avenue Partners, LP, BlackRock Inc., VANGUARD GROUP INC, Artal Group S.A., ACADIAN ASSET MANAGEMENT LLC, JPMORGAN CHASE & CO, and TLS Advisors LLC. This page lists 64 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
69
Q3 2023 holders
64
Holder diff
-5
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 Value $ Q3 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .